Neu 120
/ Neurim
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 08, 2014
Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced Dyskinesia
(clinicaltrials.gov)
- P1/2; N=8; Terminated; Sponsor: Neurim Pharmaceuticals Ltd.; N=20 -> 8 ; Active, not recruiting -> Terminated
Enrollment change • Trial termination • Biosimilar • Growth Hormone • Immunology • Parkinson's Disease
1 to 1
Of
1
Go to page
1